Parliamentary QA
Singaporeans Diagnosed with Spinal Muscular Atrophy and Cost of Treatment
22 March 2023
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
NOTICE PAPER NO. 1804
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR THE SITTING OF PARLIAMENT ON 22 MARCH 2023
Name and Constituency of Member of Parliament
Mr Chua Kheng Wee Louis
MP for Sengkang GRC
Question No. 2829
To ask the Minister for Health (a) what is the number of Singaporeans currently diagnosed with Spinal Muscular Atrophy (SMA); (b) what are the currently approved treatment options for SMA; and (c) what is the average cost of such treatments before and after any applicable Government subsidies.
Answer
1 There are currently about 40 to 50 persons in Singapore diagnosed with Spinal Muscular Atrophy (SMA). Risdiplam is the only treatment option registered with and approved by HSA. It costs around $375,000 a year in our public healthcare institutions.